regulatory
confidence high
sentiment positive
materiality 0.45
Aikido Pharma regains compliance with Nasdaq minimum bid price rule
Dominari Holdings Inc.
- Received Nasdaq letter on June 23, 2022 confirming compliance with Listing Rule 5550(a)(2).
- Closing bid price was at or above $1.00 for 11 consecutive business days from June 7-22, 2022.
- Nasdaq considers the deficiency matter closed; no further action required.
- Press release issued June 28, 2022 announcing the compliance status.